Evidence map›Paper›PMID 24458266›Full record

ArticleChest2014

Heightened plasma levels of heme oxygenase-1 and tissue inhibitor of metalloproteinase-4 as well as elevated peripheral neutrophil counts are associated with TB-diabetes comorbidity.

Bruno B Andrade, Nathella Pavan Kumar, Rathinam Sridhar, Vaithilingam V Banurekha, Mohideen S Jawahar, Thomas B Nutman, Alan Sher, Subash Babu

Open access · bronzeAbstract read
In one paragraph

Article in Chest, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Diabetic Nephropathy and Gaseous Modulators.Antioxidants (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Convergence of non-communicable diseases and tuberculosis: a two-way street?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Bruno B AndradeImmunobiology Section, Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD. Electronic address: andradebd@niaid.nih.gov.
Nathella Pavan KumarNational Institutes of Health, International Center for Excellence in Research, Chennai, India; National Institute for Research in Tuberculosis, Chennai, India.
Rathinam SridharGovernment Stanley Medical Hospital, Chennai, India.
Vaithilingam V BanurekhaNational Institute for Research in Tuberculosis, Chennai, India.
Mohideen S JawaharNational Institute for Research in Tuberculosis, Chennai, India.
Thomas B NutmanImmunobiology Section, Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD.
Alan SherImmunobiology Section, Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD.
Subash BabuImmunobiology Section, Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD; National Institutes of Health, International Center for Excellence in Research, Chennai, India.
National Institutes of Health · USInternational Centers for Excellence in Research · INNational Institute of Research in Tuberculosis · INStanley Medical College · IN

Funding

India International Center for Excellence in ResearchZIAAI001065 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI NUTMAN, THOMAS · 2009 to 2025
$19.0M
Regulation Of Immunopathology In Bacterial And Parasitic DiseaseZIAAI000843 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SHER, ALAN · 2009 to 2022
$11.1M
6 · The paper itself

Abstract

backgroundThe increased prevalence of type 2 diabetes mellitus (T2DM) in countries endemic for TB poses a serious complication in the clinical management of this major infectious disease. Understanding the impact of T2DM on TB and the determinants of comorbidity is critical in responding to this growing public health problem with better therapeutic approaches. Here, we performed an exploratory study assessing a series of biologic parameters that could serve as markers of pathogenesis in TB with T2DM.

methodsCross-sectional analyses of levels of heme oxygenase-1 (HO-1), acute phase proteins, tissue metalloproteinases, and tissue inhibitors of metalloproteinase (TIMPs) as well as cytokines and chemokines were performed in plasma samples from individuals with active pulmonary TB or with coincident TB and T2DM from South India.

resultsCompared with patients with TB without diabetes, those with coincident T2DM exhibited increased Mycobacterium tuberculosis bacillary loads in sputum. Plasma levels of HO-1 but not of other acute phase proteins were higher in patients with TB and T2DM than in patients without diabetes, independent of bacillary sputum loads. HO-1 concentrations also positively correlated with random plasma glucose, circulating glycosylated hemoglobin, and low-density lipoprotein levels. Moreover, patients with coincident TB and T2DM exhibited increased plasma levels of TIMP-4 and elevated peripheral blood neutrophil counts, which, when considered together with HO-1, resulted in increased power to discriminate individuals with active TB with and without T2DM.

conclusionsElevated plasma levels of HO-1 and TIMP-4 and peripheral blood neutrophil counts are potential single and combined markers of pathogenesis in TB and T2DM.

Indexed as

Acute-Phase ProteinsAdultAgedBiomarkersCell CountChemokinesComorbidityCross-Sectional StudiesCytokinesDiabetes Mellitus, Type 2FemaleHeme Oxygenase-1HumansIndiaMaleMiddle AgedAcute-Phase ProteinsBiomarkersChemokinesCytokinesHeme Oxygenase-1Tissue Inhibitor of Metalloproteinase-4Tissue Inhibitor of Metalloproteinases

Identifiers

PMID24458266
PMCPMC4042512
OpenAlexW2046626372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.